New research reveals the COVID-19 virus may be resisting antiviral treatments. Nirmatrelvir and remdesivir reduce severe symptoms in high-risk patients. However, long-term use of these drugs allows the virus to evolve and resist treatment. Patients with compromised immune systems face the highest risk. They require longer treatment, which gives the virus more time to mutate. […]